Aquamin supplement for preventing pouch inflammation after J-pouch surgery
Part of Digestive system clinical trials.
This study tests whether a natural supplement called Aquamin (a red algae-derived mineral source) can help prevent inflammation in people who have had surgery for ulcerative colitis and now have a J-pouch. It aims to see if this supplement reduces pouch inflammation and related symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had ulcerative colitis and have a J-pouch (formed from your small intestine) for no more than 9 months
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use birth control
- You do not have Crohn's disease or any serious stomach, intestinal, or bleeding disorders
- You have not taken calcium, magnesium, or fiber supplements (except plain multivitamins) in the last 30 days
- You have not used NSAIDs (like ibuprofen or naproxen) except for occasional pain relief or low-dose aspirin
- You have not used steroids or antibiotics recently, unless short-term use for a flare-up after study starts
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1/2 study tests EXE-346, a live probiotic given to people with an IPAA pouch who have frequent bowel movements. It aims to see if the treatment can safely lower how often you have bowel movements each day.
This trial compares two different J-pouch sizes (10 cm vs. 15 cm) during surgery for ulcerative colitis or FAP. The goal is to see if one size leads to better outcomes.
This study tests whether a special fibre supplement can reduce inflammation in people with active ulcerative colitis. You take the supplement daily for a few weeks, and researchers check how it affects your symptoms and gut health.
This trial tests whether a prebiotic supplement can improve symptoms of ulcerative colitis. It may be a good option for people with active symptoms who are already on stable medications.
This trial tests if etrasimod can prevent pouchitis, which is inflammation of the surgically created internal pouch, in people who have had their colon removed due to ulcerative colitis. If you are at high risk for pouchitis or have had only one episode, this study may help keep your pouch healthy.
This study tests whether the medicine tirzepatide (Mounjaro) can reduce frequent bowel movements in people with a J-pouch after ulcerative colitis surgery. It aims to improve quality of life by decreasing the number of daily bowel movements.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.